The report presents EU-level actions to address the challenges that were experienced during the COVID-19 pandemic and the outbreak of mpox disease in setting up adequately sized clinical trials across multiple member states.
Organised in June 2023, with participation from national competent authorities, ethics committee representatives, and academic sponsors, the workshop emphasised the need for larger studies across multiple European countries and faster recruitment and delivery of conclusive results with accelerated timelines during public health emergencies.
